Results 11 to 20 of about 2,350 (157)
T cell expression of CIITA represses Th1 immunity [PDF]
Despite the fact that major histocompatibility complex class II transactivator (CIITA) has been known to be involved in Th1/Th2 balance in addition to its major role as a master regulator for the expression of MHC class II genes, the exact role of CIITA ...
Chung, DH +8 more
core +4 more sources
Non-Immune-Mediated, p27-Associated, Growth Inhibition of Glioblastoma by Class-II-Transactivator (CIITA) [PDF]
Background: Previous works have shown that the expression of Class-II-Transactivator (CIITA) in tumor cells reduces the growth of glioblastoma (GB) in animal models, but immune effects cannot solely explain this.
A Katherine Tan +7 more
doaj +4 more sources
CIITA (MHC class II transactivator) [PDF]
Review on CIITA (MHC class II transactivator), with data on DNA, on the protein encoded, and where the gene is ...
Huret, JL
core +2 more sources
Class II transactivator (CIITA) enhances cytoplasmic processing of HIV-1 Pr55Gag. [PDF]
The Pr55(gag) (Gag) polyprotein of HIV serves as a scaffold for virion assembly and is thus essential for progeny virion budding and maturation. Gag localizes to the plasma membrane (PM) and membranes of late endosomes, allowing for release of infectious
Kristen A Porter +4 more
doaj +2 more sources
Polymorphisms in the CIITA −168A/G (rs3087456) and CIITA +1614G/C (rs4774) may influence severity in multiple sclerosis patients [PDF]
It is currently unknown how genetic factors may influence the clinical course of multiple sclerosis (MS). Objective: We examined the impact of CIITA polymorphisms −168A/G (rs3087456) and +1614G/C (rs4774) on the risk of disability progression, severity ...
Valéria Coelho Santa Rita Pereira +10 more
doaj +4 more sources
Background Osteoarthritis (OA) involves progressive extracellular matrix (ECM) degradation in articular cartilage. We previously revealed that the m6A demethylase ALKBH5 stabilizes Runx2 mRNA in chondrocytes via YTHDF1, thereby increasing MMP and ADAMTS ...
Guanghua Nie +6 more
doaj +3 more sources
Background Glioblastoma (GBM) is a highly malignant brain tumor with poor outcome, despite current therapies. CIITA-modified tumor cells, capable of presenting antigens via MHC-II, show promise in eliciting effective antitumor immune responses.
Andrea Gatta +7 more
doaj +2 more sources
Adenoviral delivery of the CIITA transgene induces T‐cell‐mediated killing in glioblastoma organoids [PDF]
The immunosuppressive nature of the tumor microenvironment poses a significant challenge to effective immunotherapies against glioblastoma (GB). Boosting the immune response is critical for successful therapy.
Ilaria Salvato +13 more
doaj +3 more sources
CIITA encodes the 'master regulator' of the expression of major histocompatibility complex class II genes. A new layer of complexity has been identified in the control of CIITA expression, which involves the formation of a complex three-dimensional chromatin structure promoted by interactions among many distant regulatory elements.
Reith, Walter, Boss, Jeremy M.
openaire +2 more sources
Identification of a Nuclear Export Sequence in the MHC CIITA [PDF]
Abstract Initiation of an immune response through expression of MHC class II and related genes is under the control of the CIITA. Normally found in both the cytoplasm and nucleus, CIITA is tightly controlled by a variety of posttranslational modifications as well as interactions with other nuclear and cytoplasmic factors, whereas ...
Emily, Chiu +4 more
openaire +2 more sources

